JP2015511957A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015511957A5 JP2015511957A5 JP2014560367A JP2014560367A JP2015511957A5 JP 2015511957 A5 JP2015511957 A5 JP 2015511957A5 JP 2014560367 A JP2014560367 A JP 2014560367A JP 2014560367 A JP2014560367 A JP 2014560367A JP 2015511957 A5 JP2015511957 A5 JP 2015511957A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- ethoxy
- arginine
- phosphonoethoxy
- naphthyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FTJSYEGCLGJJIM-UHFFFAOYSA-N Cc1c(CCc2cc(c(ccc(CCC(O)=O)c3)c3nc3O)c3nc2)ccc(OCCOCCOCCP(O)(O)=O)c1 Chemical compound Cc1c(CCc2cc(c(ccc(CCC(O)=O)c3)c3nc3O)c3nc2)ccc(OCCOCCOCCP(O)(O)=O)c1 FTJSYEGCLGJJIM-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261608011P | 2012-03-07 | 2012-03-07 | |
| US61/608,011 | 2012-03-07 | ||
| PCT/EP2013/054548 WO2013131985A1 (en) | 2012-03-07 | 2013-03-07 | Immunologically useful arginine salts |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015511957A JP2015511957A (ja) | 2015-04-23 |
| JP2015511957A5 true JP2015511957A5 (https=) | 2016-04-28 |
| JP6325986B2 JP6325986B2 (ja) | 2018-05-16 |
Family
ID=47843276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014560367A Active JP6325986B2 (ja) | 2012-03-07 | 2013-03-07 | 免疫学的に有用なアルギニン塩 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9320748B2 (https=) |
| EP (1) | EP2822947B1 (https=) |
| JP (1) | JP6325986B2 (https=) |
| CN (1) | CN104203946B (https=) |
| AU (1) | AU2013229466A1 (https=) |
| CA (1) | CA2865759C (https=) |
| CY (1) | CY1118091T1 (https=) |
| DK (1) | DK2822947T3 (https=) |
| ES (1) | ES2597755T3 (https=) |
| HR (1) | HRP20161354T1 (https=) |
| HU (1) | HUE030175T2 (https=) |
| LT (1) | LT2822947T (https=) |
| MX (1) | MX346678B (https=) |
| PL (1) | PL2822947T3 (https=) |
| PT (1) | PT2822947T (https=) |
| RU (1) | RU2014140336A (https=) |
| SI (1) | SI2822947T1 (https=) |
| WO (1) | WO2013131985A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
| WO2012117377A1 (en) | 2011-03-02 | 2012-09-07 | Novartis Ag | Combination vaccines with lower doses of antigen and/or adjuvant |
| MX372965B (es) | 2012-03-08 | 2020-04-01 | Glaxosmithkline Biologicals Sa | Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo. |
| BE1022857A1 (fr) | 2014-03-26 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Immunisation contre staphylococcus aureus |
| EP3061826A1 (en) | 2015-02-27 | 2016-08-31 | Novartis AG | Flavivirus replicons |
| WO2021178306A1 (en) * | 2020-03-01 | 2021-09-10 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
| WO2022192097A1 (en) * | 2021-03-06 | 2022-09-15 | Mind Medicine, Inc. | Formulations of psilocin that have enhanced stability |
| GB202215414D0 (en) | 2022-10-18 | 2022-11-30 | Glaxosmithkline Biologicals Sa | Vaccine |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6699474B1 (en) | 1990-08-20 | 2004-03-02 | Erich Hugo Cerny | Vaccine and immunserum against drugs of abuse |
| DE69333110T2 (de) | 1992-03-02 | 2004-05-06 | Chiron S.P.A. | Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose |
| FR2718452B1 (fr) | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
| JPH10502365A (ja) | 1994-07-01 | 1998-03-03 | リカン・リミテッド | ヘリコバクタータンパク質およびワクチン |
| WO1997025429A1 (en) | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| WO2002002606A2 (en) | 2000-07-03 | 2002-01-10 | Chiron S.P.A. | Immunisation against chlamydia pneumoniae |
| FR2827605B1 (fr) | 2001-07-20 | 2004-07-16 | Pf Medicament | Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin |
| CN100515494C (zh) | 2001-12-12 | 2009-07-22 | 启龙有限公司 | 抗沙眼衣原体的免疫 |
| GB0211118D0 (en) | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
| HUE031886T2 (en) | 2002-10-11 | 2017-08-28 | Glaxosmithkline Biologicals Sa | Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines |
| CN1812809A (zh) | 2003-06-26 | 2006-08-02 | 希龙公司 | 用于沙眼衣原体的免疫原性组合物 |
| CA2557353A1 (en) | 2004-03-02 | 2005-09-15 | Chiron Corporation | Immunogenic compositions for chlamydia pneunomiae |
| AU2006214064B2 (en) | 2005-02-18 | 2012-04-26 | J. Craig Venter Institute, Inc. | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| NZ599345A (en) | 2005-02-18 | 2013-07-26 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic Escherichia Coli |
| EP1891096A2 (en) | 2005-05-12 | 2008-02-27 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions for chlamydia trachomatis |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| AU2006341122B2 (en) | 2005-12-22 | 2013-08-22 | Novartis Vaccines And Diagnostics, Srl. | Chlamydial antigens |
| WO2008020330A2 (en) | 2006-08-16 | 2008-02-21 | Novartis Ag | Immunogens from uropathogenic escherichia coli |
| WO2009050586A1 (en) | 2007-10-19 | 2009-04-23 | Novartis Ag | Meningococcal vaccine formulations |
| MX2011010735A (es) | 2009-04-14 | 2012-01-25 | Novartis Ag | Composiciones para inmunizacion contra staphylococcus aureus. |
| RU2011154363A (ru) | 2009-06-01 | 2013-07-20 | Новартис Аг | Комбинации клад rrgb пневмококков |
| CA2765112A1 (en) * | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
| US20110076300A1 (en) | 2009-08-27 | 2011-03-31 | Mariagrazia Pizza | Hybrid Polypeptides Including Meningococcal fHBP Sequences |
| ES2443952T3 (es) * | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
| ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
| US10286056B2 (en) | 2011-01-27 | 2019-05-14 | Glaxosmithkline Biologicals S.A. | Adjuvant nanoemulsions with crystallisation inhibitors |
| SG11201400210RA (en) * | 2011-09-01 | 2014-03-28 | Novartis Ag | Adjuvanted formulations of staphylococcus aureus antigens |
-
2013
- 2013-03-07 MX MX2014010423A patent/MX346678B/es active IP Right Grant
- 2013-03-07 LT LTEP13708142.8T patent/LT2822947T/lt unknown
- 2013-03-07 EP EP13708142.8A patent/EP2822947B1/en active Active
- 2013-03-07 WO PCT/EP2013/054548 patent/WO2013131985A1/en not_active Ceased
- 2013-03-07 US US14/381,513 patent/US9320748B2/en active Active
- 2013-03-07 SI SI201330288A patent/SI2822947T1/sl unknown
- 2013-03-07 JP JP2014560367A patent/JP6325986B2/ja active Active
- 2013-03-07 CN CN201380012851.1A patent/CN104203946B/zh active Active
- 2013-03-07 RU RU2014140336A patent/RU2014140336A/ru not_active Application Discontinuation
- 2013-03-07 HR HRP20161354TT patent/HRP20161354T1/hr unknown
- 2013-03-07 ES ES13708142.8T patent/ES2597755T3/es active Active
- 2013-03-07 CA CA2865759A patent/CA2865759C/en active Active
- 2013-03-07 PL PL13708142T patent/PL2822947T3/pl unknown
- 2013-03-07 DK DK13708142.8T patent/DK2822947T3/en active
- 2013-03-07 PT PT137081428T patent/PT2822947T/pt unknown
- 2013-03-07 AU AU2013229466A patent/AU2013229466A1/en not_active Abandoned
- 2013-03-07 HU HUE13708142A patent/HUE030175T2/en unknown
-
2016
- 2016-10-10 CY CY20161101006T patent/CY1118091T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015511957A5 (https=) | ||
| JP2013534248A5 (https=) | ||
| CN112469713A (zh) | 芳基磷氧化物类衍生物抑制剂、其制备方法和应用 | |
| RU2014140336A (ru) | Иммунологически полезные соли аргинина | |
| JP2013515742A5 (https=) | ||
| JP2014525429A5 (https=) | ||
| JP2018531941A5 (https=) | ||
| JP2014051497A5 (https=) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| HRP20170433T1 (hr) | Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci | |
| WO2015017821A3 (en) | Therapeutically active compounds and their methods of use | |
| JP2016532722A5 (https=) | ||
| JP2014500861A5 (https=) | ||
| JP2014507446A5 (https=) | ||
| GEP201706780B (en) | Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
| JP2016531894A5 (https=) | ||
| JP2019516739A5 (https=) | ||
| JP2012513416A5 (https=) | ||
| JP2016516074A5 (https=) | ||
| BR112013003439A2 (pt) | "inibidores de oxadiazol de produção de leucotrieno" | |
| JP2016534081A5 (ja) | ゾレドロン酸の増強された経口バイオアベイラビリティーを有する経口剤形を調製する方法 | |
| JP2015522037A5 (https=) | ||
| JP2015516419A5 (https=) | ||
| JP2012523458A5 (https=) | ||
| WO2015011120A3 (en) | Salts of dasatinib in crystalline form |